Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-11 Sale | 2024-11-13 4:04 pm | Emergent BioSolutions Inc. | EBS | White Marvin L Director | 14,287 | $11.97 | $171,015 | 54,092 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-17 Option Award | 2024-07-19 4:34 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 22,325 | $0 | 22,325 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 9:40 pm | N/A 2031-05-22 | Emergent BioSolutions Inc. | EBS | White Marvin L Director | 43,178 | $0 | 94,127 (Direct) | View |
| 2024-03-02 Exercise | 2024-03-05 4:06 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 22,501 | $0 | 102,847 (Direct) | View |
| 2024-01-28 Exercise | 2024-01-30 6:02 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 4,792 | $0 | 44,929 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 7:09 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | White Marvin L Director | 33,847 | $0 | 50,949 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-07 4:37 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 77,500 | $0 | 136,805 (Direct) | View |
| 2023-03-03 Exercise | 2023-03-07 4:37 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 9,582 | $0 | 136,805 (Direct) | View |
| 2023-01-29 Exercise | 2023-01-30 1:07 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 4,791 | $0 | 35,347 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-07 5:23 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 28,750 | $0 | 28,750 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 4:18 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | White Marvin L Director | 8,446 | $0 | 17,102 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-04 6:13 pm | N/A 2032-03-03 | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 28,750 | $0 | 28,750 (Direct) | View |
| 2022-01-29 Exercise | 2022-02-01 6:01 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 4,792 | $0 | 35,347 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 5:01 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | White Marvin L Director | 5,027 | $0 | 8,656 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-17 9:03 pm | N/A 2031-01-29 | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 57,500 | $0 | 57,500 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-05 5:28 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | White Marvin L Director | 3,629 | $0 | 3,629 (Direct) | View |
Ownership | 2020-10-05 5:27 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | White Marvin L Director | 0 | $0 | 0 (Direct) | View |
| 2020-07-27 Disposition | 2020-07-29 9:40 pm | N/A 2021-05-22 | Aptevo Therapeutics Inc. | APVO | White Marvin L CEO and President | 49,348 | $0 | 21,438 (Direct) | View |
| 2020-07-27 Option Award | 2020-07-29 9:40 pm | N/A 2030-07-26 | Aptevo Therapeutics Inc. | APVO | White Marvin L CEO and President | 21,438 | $0 | 21,438 (Direct) | View |
| 2020-02-18 Option Award | 2020-03-19 6:35 pm | N/A 2030-02-17 | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 303,200 | $0 | 303,200 (Direct) | View |